Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Christophers

Showing results (221-230 of 356) with videos related to

Pageof 36
Sort By:
Journal of the American Academy of Dermatology|January 1, 1987
Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasisT Henseler, E Christophers, H Hönigsmann, et al.
Scandinavian Journal of Immunology|January 1, 1992
Infiltrating neutrophils differ from circulating neutrophils when stimulated with C5a, NAP-1/IL-8, LTB4 and FMLPU Mrowietz, J M Schröder, J Brasch, et al.
The Journal of Investigative Dermatology|July 1, 1996
Dermatophytes contain a novel lipid-like leukocyte activatorB Kahlke, J Brasch, E Christophers, et al.
Journal of Leukocyte Biology|January 1, 1996
Role of eosinophil-chemotactic C-C chemokines in cutaneous inflammationJ M Schröder, N Noso, M Sticherling, et al.
The Journal of Biological Chemistry|November 22, 2000
Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibioticJ Harder, J Bartels, E Christophers, et al.
Acta Dermato-Venereologica|March 23, 1999
Interleukin-8 plays its role at local level in psoriasis vulgarisM Sticherling, W Sautier, J M Schröder, et al.
The British Journal of Dermatology|November 1, 1980
Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serumG Kawohl, B Szperalski, J M Schröder, et al.
The Journal of Investigative Dermatology|October 1, 1993
Time- and stimulus-dependent secretion of NAP-1/IL-8 by human fibroblasts and endothelial cellsM Sticherling, F Hetzel, J M Schröder, et al.
Scandinavian Journal of Immunology|September 1, 1989
Recombinant human tumour necrosis factor beta (lymphotoxin) lacks chemotactic activity for human peripheral blood neutrophils, monocytes, and T cellsU Mrowietz, T Ternowitz, J M Schröder, et al.
Cancer Biotherapy|January 1, 1995
Diabetes mellitus in cancer patients treated with combination interleukin 2 and alpha-interferonR P Whitehead, A Hauschild, E Christophers, et al.
Pageof 36

Showing results (221-230 of 356) with videos related to

Sort By:
Pageof 36
Journal of the American Academy of Dermatology|January 1, 1987
Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasisT Henseler, E Christophers, H Hönigsmann, et al.
Scandinavian Journal of Immunology|January 1, 1992
Infiltrating neutrophils differ from circulating neutrophils when stimulated with C5a, NAP-1/IL-8, LTB4 and FMLPU Mrowietz, J M Schröder, J Brasch, et al.
The Journal of Investigative Dermatology|July 1, 1996
Dermatophytes contain a novel lipid-like leukocyte activatorB Kahlke, J Brasch, E Christophers, et al.
Journal of Leukocyte Biology|January 1, 1996
Role of eosinophil-chemotactic C-C chemokines in cutaneous inflammationJ M Schröder, N Noso, M Sticherling, et al.
The Journal of Biological Chemistry|November 22, 2000
Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibioticJ Harder, J Bartels, E Christophers, et al.
Acta Dermato-Venereologica|March 23, 1999
Interleukin-8 plays its role at local level in psoriasis vulgarisM Sticherling, W Sautier, J M Schröder, et al.
The British Journal of Dermatology|November 1, 1980
Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serumG Kawohl, B Szperalski, J M Schröder, et al.
The Journal of Investigative Dermatology|October 1, 1993
Time- and stimulus-dependent secretion of NAP-1/IL-8 by human fibroblasts and endothelial cellsM Sticherling, F Hetzel, J M Schröder, et al.
Scandinavian Journal of Immunology|September 1, 1989
Recombinant human tumour necrosis factor beta (lymphotoxin) lacks chemotactic activity for human peripheral blood neutrophils, monocytes, and T cellsU Mrowietz, T Ternowitz, J M Schröder, et al.
Cancer Biotherapy|January 1, 1995
Diabetes mellitus in cancer patients treated with combination interleukin 2 and alpha-interferonR P Whitehead, A Hauschild, E Christophers, et al.
Pageof 36